Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -234,330 | -182,393 | -125,373 | -78,882 | -28,837 |
| Depreciation Amortization | 2,560 | 2,061 | 1,624 | 906 | 860 |
| Income taxes - deferred | -8,864 | -292 | -44 | 58 | -285 |
| Accounts receivable | -614 | 130 | 1,757 | -459 | -1,032 |
| Other Working Capital | 5,713 | 5,902 | -676 | -2,647 | -26,089 |
| Other Operating Activity | 54,146 | 23,480 | 24,282 | 11,522 | 7,259 |
| Operating Cash Flow | $-181,389 | $-151,112 | $-98,430 | $-69,502 | $-48,124 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 168,075 | -105,768 | -293,109 | -244,720 | -14,187 |
| PPE Investments | -3,075 | -5,617 | -2,894 | -2,050 | -2,637 |
| Investing Cash Flow | $165,000 | $-111,385 | $-296,003 | $-246,770 | $-16,824 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -16,743 |
| Common Stock Issued | 12,130 | 353,522 | 278,471 | 447,543 | 102,538 |
| Financing Cash Flow | $12,130 | $353,522 | $278,471 | $447,543 | $85,795 |
| Exchange Rate Effect | -1,672 | 376 | -2,484 | -592 | -593 |
| Beginning Cash Position | 148,643 | 57,242 | 175,688 | 45,009 | 24,755 |
| End Cash Position | 142,712 | 148,643 | 57,242 | 175,688 | 45,009 |
| Net Cash Flow | $-5,931 | $91,401 | $-118,446 | $130,679 | $20,254 |
| Free Cash Flow | |||||
| Operating Cash Flow | -181,389 | -151,112 | -98,430 | -69,502 | -48,124 |
| Capital Expenditure | -3,075 | -5,617 | -2,894 | -2,050 | -2,637 |
| Free Cash Flow | -184,464 | -156,729 | -101,324 | -71,552 | -50,761 |